ZONews
AFSBusinessBussinessCarCareer
  • KONTAKT
  • AFS
  • Business
  • Bussiness
  • Car
  • Career
  • Celebrity
  • Digital Products
  • Education
  • Entertainment
  • Fashion
  • Film
  • Food
  • Games
  • General Health
  • Health
  • Health Awareness
  • Healthy
  • Healthy Lifestyle
  • History Facts
  • Household Appliances
  • Internet
  • Investment
  • Law
  • Lifestyle
  • Loans&Mortgages
  • Luxury Life Style
  • movie
  • Music
  • Nature
  • News
  • Opinion
  • panorama
  • Pet
  • Plant
  • Politics
  • promis
  • Recommends
  • Science
  • Self-care
  • services
  • Smart Phone
  • sport
  • Sports
  • Style
  • Technology
  • tire
  • Travel
  • US
  • World
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients
Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion

Beliebt

  • Lilly, Novo lock horns in India's obesity drug race
  • Weight-loss pill approval set to accelerate food industry product overhauls
  • Indian rocket launches record-breaking BlueBird 6 smartphone satellite to orbit (video)
  • I'm 18 and founded an AI startup. I have to wake up at 3 a.m. to work on it before school, but it's worth every sleepless night.
  • Rick Steves' Favorite Time To Visit Spain Has Lower Prices And Fewer Crowds
  • Watch South Korean startup Innospace attempt its 1st-ever orbital launch today
  • US FDA grants market authorization to six on! PLUS nicotine pouch products

Für Sie

Copyright © 2022 Alle Rechte vorbehalten
Impressum|Datenschutzerklärung|Kontakt|Nutzungsbedingungen